首页> 外国专利> PHARMACEUTICAL COMPOSITION INCLUDING MIGRATORY FACTOR FOR GUIDING PLURIPOTENT STEM CELLS TO INJURY

PHARMACEUTICAL COMPOSITION INCLUDING MIGRATORY FACTOR FOR GUIDING PLURIPOTENT STEM CELLS TO INJURY

机译:药物组合物,包括引导多能干细胞损伤的迁移因子

摘要

The purpose of the present invention is to identify a migratory factor that guides pluripotent stem cells (Muse cells) useful in new medical applications to damage, and to provide a pharmaceutical composition that includes the migratory factor for promoting tissue regeneration in regenerative medicine that makes use of Muse cells. In the present invention, a receptor that is specifically expressed in Muse cells rather than non-Muse cells was identified, and it was confirmed that a ligand for this receptor can function as a migratory factor. In the present invention, sphingosine-1-phosphate (S1P) was identified as a migratory factor, and thus, the present invention pertains to a pharmaceutical composition for guiding pluripotent stem cells to damage, the composition including SIP as an active ingredient.
机译:本发明的目的是鉴定可用于损伤新医学应用的多能干细胞(Muse细胞)的迁移因子,并提供包含用于促进使用的再生药物组织再生的迁移因子的药物组合物缪斯细胞。在本发明中,鉴定了在Muse细胞中特异性表达而不是非缪斯细胞的受体,并证实该受体的配体可以用作迁移因子。在本发明中,将鞘氨酸-1-磷酸(S1P)鉴定为迁移因子,因此,本发明涉及用于引导多能干细胞的药物组合物,其将包括SIP作为活性成分的组合物。

著录项

  • 公开/公告号EP2962698B1

    专利类型

  • 公开/公告日2021-05-12

    原文格式PDF

  • 申请/专利权人

    申请/专利号EP20140756298

  • 申请日2014-02-28

  • 分类号A61K45;A61K31/4164;A61K31/417;A61K31/42;A61K31/4439;A61K31/661;A61K35/12;A61K35/28;A61K35/36;A61P9/10;A61P17/02;A61P29;A61P35;A61P43;

  • 国家 EP

  • 入库时间 2022-08-24 18:39:51

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号